266 related articles for article (PubMed ID: 28527632)
1. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
Sharma S; Taliyan R; Singh S
Behav Brain Res; 2015 Sep; 291():306-314. PubMed ID: 26048426
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domain of the heavy chain of tetanus toxin given by intramuscular injection causes neuroprotection and improves the motor behavior in rats treated with 6-hydroxydopamine.
Mendieta L; Bautista E; Sánchez A; Guevara J; Herrando-Grabulosa M; Moran J; Martínez R; Aguilera J; Limón ID
Neurosci Res; 2012 Oct; 74(2):156-67. PubMed ID: 22967672
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
5. Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.
Oró D; Yudina T; Fernández-Varo G; Casals E; Reichenbach V; Casals G; González de la Presa B; Sandalinas S; Carvajal S; Puntes V; Jiménez W
J Hepatol; 2016 Mar; 64(3):691-8. PubMed ID: 26519601
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.
Tunçel N; Korkmaz OT; Tekin N; Şener E; Akyüz F; Inal M
J Mol Neurosci; 2012 Jan; 46(1):51-7. PubMed ID: 21850490
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
9. Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson's disease symptoms.
Mishra A; Chandravanshi LP; Trigun SK; Krishnamurthy S
Biochem Pharmacol; 2018 Sep; 155():479-493. PubMed ID: 30040928
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
Haghdoost-Yazdi H; Piri H; Faraji A; Fraidouni N; Dargahi T; Mahmudi M; Alipour Heidari M
Neurol Res; 2016 Apr; 38(4):294-300. PubMed ID: 27098232
[TBL] [Abstract][Full Text] [Related]
12. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
13. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease.
Patricio F; Parra I; Martínez I; Pérez-Severiano F; Montes S; Aguilera J; Limón ID; Tizabi Y; Mendieta L
Neurotox Res; 2019 Apr; 35(3):699-710. PubMed ID: 30607904
[TBL] [Abstract][Full Text] [Related]
15. Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
Mabandla MV; Nyoka M; Daniels WM
Brain Res; 2015 Oct; 1622():64-71. PubMed ID: 26111646
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats.
Singh S; Kumar P
Inflammopharmacology; 2017 Feb; 25(1):69-79. PubMed ID: 27853890
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: A possible implication of endothelin-1.
Nassar SZ; Hassaan PS; Abdelmonsif DA; ElAchy SN
Life Sci; 2018 May; 201():89-101. PubMed ID: 29588134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
